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Image-based screening is used to measure a variety of phenotypes in cells and whole organisms.
Combined with perturbations such as RNA interference, small molecules, and mutations, such
screens are a powerful method for gaining systematic insights into biological processes. Screens
have been applied to study diverse processes, such as protein-localization changes, cancer cell
vulnerabilities, and complex organismal phenotypes. Recently, advances in imaging and image-
analysis methodologies have accelerated large-scale perturbation screens. Here, we describe
the state of the art for image-based screening experiments and delineate experimental approaches
and image-analysis approaches as well as discussing challenges and future directions, including
leveraging CRISPR/Cas9-mediated genome engineering.Introduction
For over a century, genetic screens have attempted to classify
mutations on the basis of visual phenotypes, perhaps initiating
with Thomas Hunt Morgan, who at the beginning of the last cen-
tury identified a spontaneous mutation in Drosophila mela-
nogaster that produced white eyes instead of red eyes (Morgan,
1910). Morgan followed up not only bymapping themutation to a
chromosome but also by using X-ray radiation to induce muta-
tions and then analyzing the phenotypic consequences and
inheritance patterns, thereby laying the foundation of modern
genetics.
Complex visual phenotypes have subsequently been de-
ployed to systematically identify genes involved in embryonic
development (Nu¨sslein-Volhard and Wieschaus, 1980) and to
identify genes that enhance or suppress known mutations
(e.g., Karim et al., 1996) (Figure 1A). Genetic screens for visual
phenotypes have been among the most successful genetic ap-
proaches used over the past few decades (Bier, 2005; St John-
ston, 2002). In particular, the richness and complexity of visual
phenotypes are important factors in determining the specificity
of a gene’s effect, and visual phenotypes are an important tool
for classifying genes by similarity into pathways and processes.
Over the past two decades, major technological advances
have enabled automated microscopy screens for visual pheno-
types in cells and organisms. Cell-based assays have been
used to screen large libraries of small molecules to identify po-
tential drug candidates or to characterize gene function through
RNAi or genetic perturbations (Boutros and Ahringer, 2008;
Carpenter, 2007). Although such phenotypic high-throughput
screens first relied on relatively simple assays, such as cell
growth and viability or levels of luminescence reporter genes
(Boutros et al., 2004; Lum et al., 2003), automated microscopy
has opened new avenues for analyzing a broad spectrum of
phenotypes. Image-based assays can be used to answer
many cell-biological questions. For example, markers for stem1314 Cell 163, December 3, 2015 ª2015 Elsevier Inc.cell and differentiation pathways can be used to dissect pro-
cesses required for stem cell maintenance. Image-based assays
can also be used to measure complex cell-morphology pheno-
types to classify perturbations according to changes in cell
shape and cell behavior (Kiger et al., 2003; Liu et al., 2009).
In this Primer, we discuss the current state of the art of pheno-
typic screening in cells. We first describe different approaches to
cell-based high-content screening, then cover the design and
execution of screening experiments as well as data analysis
and exploration. We highlight advances in fluorescence-labeling
techniques and opportunities to use genome engineering to
create novel markers for image-based screens.
What Defines and Enables High-Throughput and
High-Content Screens?
In their simplest form, high-throughput screens are cell based
and measure a signal averaged over all cells within a microplate
well. The signal might be expression of a reporter gene or levels
of a small molecule such as ATP, and the cells can be assayed
following perturbation by RNAi (applied genome-wide or more
selectively) or small molecules. Generally the read-out, as it is
averaged over the whole well, disregards differences that might
exist due to individual cell responses. Homogenous cell-based
assays aremostly limited to one or twomeasurements in parallel,
such as two luminescence channels.
In contrast, microscopy-based, high-content assays allow
parallel monitoring of multiple cell phenotypes. Cells can be
modified to express fluorescently labeled proteins or stained
with fluorescent markers to allow visualization of cellular and
subcellular phenotypes. To examine cell shape changes under
different conditions or perturbations, fluorescent dyes and/or an-
tibodies have been used to stain cells for actin, tubulin, and DNA,
for example (Kiger et al., 2003; Mayer et al., 1999) (Figure 1B).
Thus, microscopy-based screens facilitate phenotype measure-
ments in individual cells and heterogeneous response analyses,
Figure 1. Example High-Content Screens
Illustrating the Range of Image-Based
Read-outs
(A) Scanning electron micrographs of adult
Drosophila eyes. Compared to the wild-type (left),
a sev-Ras1V12 transgene led to a rough eye
phenotype with misarranged and fused omma-
tidia. Adapted from Karim et al. (1996).
(B) High-resolution images of BS-C-1 cells
stained for DNA (blue) and a-tubulin (green),
showing the effect of monastrol treatment on
spindle formation. In mitotic cells, monastrol
induces a mono-astral microtubule formation.
Adapted from Mayer et al. (1999).
(C) HCT116 cells stained for DNA, a-tubulin, and
actin to extract quantitative phenotypic features
describing cell morphology as described in
Laufer et al. (2013).
(D) Drosophila cells stained as in (C), imaged
at 203 magnification for detailed analysis
of morphological phenotypes. RNAi-mediated
knockdown of Rho1 leads to enlarged, multi-
nucleated cells.
(E) Confocal micrographs of A549 cells infected with influenza A/WSN/33 virus and stained for influenza virus (green) and CD63 (red). Yellow indicates virus
particles co-localizing with CD63-labeled late endosomes. Adapted from Karlas et al. (2010).
(F) Confocal micrographs of L cells after treatment withWnt3a-conditioned medium. Nuclei are stained with DAPI (magenta), and the formation of lipid droplets is
visualized with BODIPY 493/503 staining (green). Adapted from Scott et al. (2015).which provide deeper insights into biological processes (Liberali
et al., 2015). For example, heterogeneous viral infections in a
cell population have been traced to individual cell states; other-
wise, such infections are a masked phenotype in population-
averaging experiments (Snijder et al., 2012).
The ability to silence virtually every gene in the genome cata-
lyzed the appeal of systematic visual screening. In addition, ma-
jor technological advances have expanded the reach of auto-
mated screening for visual phenotypes. These advances were
driven by improvements in microscopes, such as more stable
light sources, faster autofocus, and automation, which led to
more advanced automated microscopes. Second, advances in
fluorescent probes, new fluorescent protein variants that are
used as reporters and fusion proteins, greatly expanded the abil-
ity to visualize phenotypes. A third important area includes ad-
vances in image-analysis methodologies and the availability of
standardized software workflows that greatly reduce the efforts
necessary to extract quantitative, multi-parametric information
from images (Eliceiri et al., 2012). Together, these methodolog-
ical advances have brought high-content screening within the
reach of many academic laboratories.
Examples of Image-Based Screening
High-content assays can feature very different levels of
complexity. In this section, we highlight examples of assays
and high-throughput image-based screening experiments (see
also Figure 1).
Fluorescent Reporter Genes
Image-based screens can be used to detect changes in reporter
genes using additional data, such as cell number or cell shape, to
correlate reporter to generic cell responses (e.g., perturbations
that induce cell death). Fluorescent reporter screens have
been used to study factors that influence pluripotency marker
expression. For example, a POU5F1-GFP reporter human em-
bryonic stem cells (hESCs) cell line has been used to image
GFP levels and nuclei after perturbing the cells using agenome-wide short interfering RNA (siRNA) library (Chia et al.,
2010). The authors quantified GFP levels and compared them
to the number of nuclei per well to exclude hits that reduce gen-
eral cell viability. Similarly, Desbordes et al. (2008) have imaged
Oct4 protein levels to identify small molecules that inhibit the
pluripotent state of hESC (Desbordes and Studer, 2013; Des-
bordes et al., 2008).
Protein Localization
Visual assays are a powerful method for assessing changes in
subcellular localization of proteins that are indicative, such as
for activating signaling pathways or changes in organelle func-
tion. In a screen used to identify novel inhibitors of FOXO/Akt
signaling, Link et al. (2009) have used an image-based assay
to monitor FOXO protein localization in renal carcinoma cells
(Link et al., 2009). They transfected cells to express a tagged
version of the FOXO protein, treated cells with a library of small
molecules, and visualized FOXO localization changes through
antibody staining. This screen identified 242 small-molecule in-
hibitors (out of a library of >33,000) that blocked FOXO nuclear
transport. Similarly, perturbations can be used in cell-based as-
says to identify genes necessary for processes such as auto-
phagy. In a genome-wide RNAi screen, the co-localization of a
Sindbis virus capsid protein and autophago-lysosomes has
been detected through automated microscopy, and the authors
have identified novel candidate genes necessary for autophagy
(Orvedahl et al., 2011).
Image-based screens have also been designed to focus on a
limited set of features that are directly related to the aim of the
study. For example, to identify host cell factors required for influ-
enza infection cycles, a cell-based assay has been used to
monitor infection rate with an antibody directed against the virus,
along with a second assay used to measure residual influenza in
the supernatant (Karlas et al., 2010) (Figure 1E). Using this
approach, Karlas et al. (2010) have screened a genome-wide li-
brary of RNAi reagents in human cells for factors that change
both phenotypic features. Likewise, Ra¨mo¨ et al. (2014) haveCell 163, December 3, 2015 ª2015 Elsevier Inc. 1315
compared multiple high-content viral infection screens to
discern specific and potential off-target hits in a kinome-wide
dataset for eight different pathogens (Ra¨mo¨ et al., 2014). In
another study, the role of Wnt signaling in lipid metabolism has
been analyzed by establishing a cell-based assay that monitored
intracellular lipid droplets (Figure 1F). Using this approach, the
authors have shown that Wnt signaling influences lipid mobiliza-
tion through endocytosis (Scott et al., 2015). FACS or plate-
based cytometers have also been used to generate multi-para-
metric cell-cycle profiles in genome-wide RNAi screens
(Bjo¨rklund et al., 2006; Kittler et al., 2004).
Complex Morphological Assays
High-content screens can use a broad spectrum of cell-shape
markers to identify phenotypic changes in an unbiased manner.
The rationale behind these approaches is to use complex phe-
notypes to classify perturbations through a ‘‘guilt-by-associa-
tion’’ approach, similar to phenotypic forward genetic screens
in organisms. Perturbation often elicits similar phenotypic pro-
files when the same target or pathway is hit, which, in turn, facil-
itates grouping of perturbations without specifically knowing the
target and action mechanism. For example, Loo et al. (2007)
have screened approximately 100 drugs at different concentra-
tions and used cellular morphological markers to classify the
drugs (Loo et al., 2007). Similarly, Young et al. (2008) have
screened 6,000 small molecules and clustered compounds by
similarity to infer the mechanism (Young et al., 2008). In a further
example, Fuchs et al. (2010) have screened a genome-scale
RNAi library and clustered genes by phenotypic similarity, using
a 13-dimension feature vector that represented phenotypes
visualized by actin, tubulin, and DNA fluorescent stains (Fuchs
et al., 2010).
Fluorescent-tag labeling for proteins can also be used to visu-
alize complex phenotypes in image-based screens. In budding
yeast, Vizeacoumar et al. (2010) have introduced GFP-tagged
tubulin and genetically crossed this strain with a library of dele-
tion strains (Vizeacoumar et al., 2010). Using automated imaging
and image analysis to segment subcellular objects, the authors
calculated multiple quantitative phenotypic features, including
spindle-axis orientation and distance to the budding site.
To map gene-gene interactions, Fischer et al. (2015) have
used double RNAi and image-based phenotyping to generate
a large genetic interaction map for 21 phenotypic features in
Drosophila cells (Fischer et al., 2015). Pairwise knockdown com-
binations (2 3 2 dsRNAs) were used to detect and avoid off-
target effects. The study comprised 1,367 Drosophila genes
implicated in different cellular processes, including signaling,
chromatin, and cell-cycle regulation, and scored 21 phenotypes
in cultured cells. The multi-parametric phenotypes allow re-
searchers to infer protein function and clustered processes on
the basis of similarity. Using multiple phenotypes also facilitates
computation of directional genetic interactions and maps for
logical or temporal dependencies between genes. Similar ap-
proaches have also been feasible in mammalian cells (Laufer
et al., 2013; Roguev et al., 2013; Wang et al., 2014)
High-content imaging has also been combined with other
methods to measure whole-proteome dynamics under different
environmental conditions (Chong et al., 2015). GFP-fusion pro-
teins were used in yeast to map localization for more than1316 Cell 163, December 3, 2015 ª2015 Elsevier Inc.3,000 proteins with high-throughput, confocal microscopy in
single cells. Protein localization classifiers that were derived
through machine learning using image-derived features from
previously established protein localization have been applied
to the whole dataset. This approach has been used to determine
proteome-wide abundance as well as relocalization of proteins
after treatment with several drugs.
Perturbation Reagents
In most cases, cell-based assays use small-molecule or RNAi li-
braries as perturbation reagents. Perturbation reagent libraries
can contain many thousands of reagents in micro-well plate for-
mats. High-content screens are typically incompatible with
‘‘pooled’’ screening formats using retroviral or lentiviral delivery
of complex short-hairpin or short-guide RNA libraries. In such
screens, cells are transfected in bulk, and perturbations are iden-
tified through selection and subsequent isolation as well as
sequencing of the enriched or depleted silencing reagent (Moffat
et al., 2006; Shalem et al., 2015). Although certain cell-based
assay parameters differ between RNAi and small compound
screens (such as incubation time and use of transfection re-
agents), similar assays have been used for different perturbation
assays (Eggert et al., 2004; Sundaramurthy et al., 2013). Figure 2
shows typical workflows for image-based high-throughput
screens.
RNAi Libraries
Imaged-based experiments require RNAi in an arrayed format.
Currently, most image-based screens use siRNA, enzymatically
prepared (esi) RNA (in humans ormice) (Kittler et al., 2004, 2007),
or long double-stranded (ds) RNA (Drosophila) (Horn et al., 2010;
Ramadan et al., 2007). Genome-scale RNAi reagent libraries are
available from different academic and commercial sources.
For many organisms, in addition to genome-wide libraries,
sub-libraries for specific functional groups, e.g., all kinases and
surface proteins, have been generated, thus facilitating focused,
high-content screening experiments. Off-target effects are ama-
jor concern for all RNAi experiments (Echeverri et al., 2006). In
certain cases, libraries proceeded through several iterations to
limit off-target effects from RNAi reagents as much as possible
(Horn et al., 2010; Mohr et al., 2010) using multiple, sequence-in-
dependent reagents. Concordant multi-parametric phenotypes
have been used to predict specific reagents (Horn et al., 2011).
Small-Molecule Libraries
Depending on the focus and size of the experiment, various
small-molecule libraries, available from commercial or academic
sources, may be used. Academic screening centers have been
established at multiple locations to facilitate access to libraries,
small-molecule screening expertise, and chemistry follow-up.
Recently, several public-private partnerships have been estab-
lished to provide access to a large collection of small molecules
(Mullard, 2013; Roy et al., 2010).
Experimental Design: General Considerations
Image-based assays and establishing conditions for subsequent
high-throughput screens often require multiple iterations of pro-
tocol optimization. Many questions must be initially addressed,
including the following: What type of cells should be used?
What is the intended size of the screen? What are suitable
Figure 2. Workflows of Image-Based
Screens using Different Perturbation
Reagents
Despite differences in perturbation agent, cellular
model, or experimental scope, themain steps of an
image-based screen are similar. The library of
perturbation reagents is distributed onto assay
plates, then cells are seeded into the wells (and, if
applicable, reversely transfected with RNAi re-
agents). In microscopy screens in yeast, fluo-
rescently tagged reporters can be crossed into li-
brary mutant strains. Following an incubation time
of typically 24 to 96 hr, the cells are fixed and
stained with fluorescent probes that label the
relevant cellular features. Subsequently, the im-
ages are captured by automated microscopy and
passed on to the image-analysis pipeline. SGA:
synthetic genetic arrays.perturbation reagents? How complex should the phenotypic
read-out be? Furthermore, conducting large-scale imaging
screens differs in many aspects from conducting smaller-scale
experiments. Establishing and scaling a high-content screening
assay often requires several months, but the screen is often per-
formed in a short time frame, depending on the size of the library.
It is also important that the establishment of the experimental
assay and image-analysis workflows are tightly linked (Figure 3).
The following section describes general considerations that are
important in high-content screens.
Imaged-based screens can be performed in high-density cell
culture plates with 96, 384, or 1,536 wells; 384-well plates are
the most frequently used assay format. Alternatively, reagents
such as small molecules and siRNA have also been spotted
onto microscopy slides (Neumann et al., 2006; Wheeler et al.,
2004). The set of genes to be screened is determined by the sci-
entific question and—together with the phenotypic read-out
complexity—defines the experimental scale. The size of the
experimental set must sometimes be reduced for compatibility
with high-resolution or confocal imaging experiments. A
frequently used approach includes screening defined functional
groups, such as kinases or phosphatases. Another strategy has
been to first identify candidate genes through a genome-wide
screen and then perform a secondary screen with a more com-
plex phenotypic analysis. For example, Simpson et al. (2012) fol-
lowed this strategy when they first screened genome-wide
siRNAs for secretion regulators through assaying transport of
fluorescently labeled tsO45G to the plasma membrane, and
500 genes that inhibited secretion were identified. In a second-
ary screen, these candidates were further analyzed inmore com-
plex secondary assays using fluorescence labeling of COPI andCell 163, DCOPII coats as well as the Golgi matrix
protein GM130 (Simpson et al., 2012).
Positive and negative controls must be
added toeachplate toassessassay repro-
ducibility and normalize potential batch
effects. Fluorescent probes and/or geneti-
cally encoded fluorescent proteins must
be selected and validated in smaller-scale
experiments. Another important factor to
consider is the experimental time spanbecause, for example, this determines the number of cells that
can be seeded in high-density tissue culture plates. Often,
small-molecule screens use short incubation times (24–48 hr),
whereas RNAi screens typically require 72 hr or a longer incuba-
tion time to ensure target protein depletion. The experimental
design should also implement built-in quality controls, including
plate designs that assign a sufficient number of wells for the con-
trols. For RNAi screens, it is preferable to arrange reagents in a
random order. Some commercially available RNAi libraries are
sorted by gene name,which canproduce normalization problems
during data-analysis steps due to overrepresentation of related
genes on the same assay plate.
A crucial aspect of the assay design phase is assessing and
optimizing experimental reproducibility. Technical variations
must be reduced, error-prone pipetting steps must be limited,
and variation between the reagent or consumable lots must
be avoided. This aspect can be implemented, in part, through
automating pipetting steps by using liquid-handling robots to
prepare screening plates and seed cells as well as for staining
procedures.
Steps in Performing Image-Based Screens
Despitedifferences in assay setup, experimental scale, or pheno-
typic read-out, certain general steps are necessary for perform-
ing an image-based screen. The overall scientific question
addressed by the high-throughput experiment often dictates
the cell type used and the phenotype scored. Additionally,
many parameters are interdependent; for example, the cell type
determines transfection protocol and experimental timescale.
An imaging assay also comprises cell fixation, staining, and mi-
croscopy, whichmust be adapted for the screen. Image-analysisecember 3, 2015 ª2015 Elsevier Inc. 1317
Figure 3. Workflow and Decision Tree for
Assay Development and Image Analysis
The development of a high-throughput image-
based assays and image-analysis procedures
should ideally be done in parallel.
Step 1: Staining procedures are established at a
small scale. Selected probes should specifically
stain the structures of interest without generating a
strong unspecific background; exposure times
need to be optimized. Alternative stains need to be
tested ifmarkers are not suitable (MarkerOK?). The
staining should be tested on positive and negative
controls to ensure that the expected phenotypes
are depicted (Controls OK?). In parallel, a basic
image-analysis pipeline should be established. The
algorithms have to be modified until nuclei and cell
bodies (or subcellular structures) are segmented
correctly. Staining procedures have to bemodified,
if necessary.
Step 2: The assay is miniaturized for high-
throughput and automated to ensure high repro-
ducibility. Handling of cells is established, and the
adequate number of cells seeded is tested. If
possible, the protocol steps should be minimized;
individual steps can be combined. In parallel, the
image analysis is optimized. The quantitative fea-
tures extracted by the software must reflect rele-
vant phenotypes (Features relevant?). If necessary,
the feature selection must be changed. Also,
technical and biological reproducibility is tested,
and quality-control measures as well as data
normalization are established.
Step 3: The assay is subjected to realistic
screening conditions in a pilot screen. Critical
points such as cell survival, batch processing,
timing, and automation need to function at high-
throughput (HTS OK?). Image quality, software
performance, computational power, and data
handling and storage are assessed. Finally, a data-
analysis workflow to extract biological information
from the gained phenotypic features is set up and
tested (Classifier relevant?).
Step 4: Full screening experiment and data
analysis.steps should be implemented in parallel because this procedure
provides direct feedback on the suitability of the assay. Figure 3
provides an overview of the different assay development steps
and their interconnections. Below, we describe certain key pa-
rameters for constructing high-content screening experiments
and use examples to illustrate the parameters.
Cell Model
The cell line must be selected when assay development begins.
The cell model should be relevant to the questions to be ad-
dressed and suitable for large-scale screens. Many established
cell lines perform well in large-scale experiments, but cell char-
acteristics might change over time and may not reflect the orig-
inal biological context. Primary cells, however, often retain the
specific physiological characteristics of their tissue source or
disease context but are often difficult to expand and require
more careful handling during the experiment. In addition, pertur-
bation experiments are often more difficult to perform when
using primary cells.
For example, Nieland et al. (2014) have screened for genes
required in synapse formation. To perform the screen in primary
cells, they established generation and culture conditions for
mouse primary cortical neurons and developed an image-1318 Cell 163, December 3, 2015 ª2015 Elsevier Inc.analysis process to capture synaptogenesis through fluores-
cently labeling four process-related proteins. Due to limitations
in throughput, they screened 116 selected mouse genes
using a lentiviral shRNA library and described several novel
putative positive regulators of synapse formation (Nieland
et al., 2014). In another example, Sepp et al. (2008) were inter-
ested in primary neuron morphological phenotypes. Using fluo-
rescently labeled Drosophila primary neurons, they performed
a genome-wide screen with an imaging read-out and identified
104 conserved genes involved in neurite outgrowth (Sepp
et al., 2008).
Other experiments might require a defined mutational status
to analyze a signaling pathway or expression of specific proteins
or to introduce disease-related mutations. For example, Honar-
nejad et al. (2013) sought to elucidate the mechanisms involved
in impaired calcium homeostasis associated with presenilin-1
mutations, which is linked to familial Alzheimer’s disease. They
introduced a presenilin-1 mutant into HEK293 cells and
screened 20,000 small molecules for reversal of the induced
calcium alterations. Their screen produced 52 primary hits
and led to the identification of 4 candidates (Honarnejad et al.,
2013).
Fluorescent Probes
To visualize phenotypes, most high-content screens use fluores-
cent probes for staining or to genetically encode fluorescent pro-
teins. Fluorescent read-outs can differ; therefore, certain general
considerations apply. The simplest phenotype, e.g., number of
cells after perturbation, can be determined from low-resolution
images after DNA staining. In many cases, the imaging read-
out will be more complex with multiple fluorescent channels,
confocal microscopy, and/or live-cell imaging.
Many antibodies and fluorescent probes are available for
staining cellular features, such as a cell membrane, DNA or or-
ganelles, and certain proteins. A probe should specifically stain
the structure of interest without much background, which might
impede image analyses. Additionally, the fluorescent stain
should be sufficiently bright to allow for short exposure times,
thereby decreasing image-acquisition time. When combining
multiple fluorescent probes, it is important to avoid bleed-
through between channels. In general, researchers should use
only as many probes or antibodies as necessary to avoid pro-
longing the imaging time. In the first step, the probe should be
tested on a small scale to confirm suitability for the planned
assay. Subsequently, the probe should be tested on positive
and negative controls to ensure that the key phenotypes are
measurable.
Miniaturization and Automation
In a second step, the assaymust beminiaturized and adapted for
high-throughput settings. Often, this step involves automating
the screening procedure, including cell-seeding and pipetting
steps during fixation and staining (Laufer et al., 2014). Miniatur-
izing the imaging read-out to a 96- or 384-well format is desirable
because seeding and growing cells must be established in a
small volume. These optimization steps must address a number
of different experimental questions, such as the following: Do the
cells survive mass preparation and automated liquid handling?
Do they grow to the desired density to ensure sufficient cells
for analysis? Do they overgrow in the well, impeding proper
cell segmentation by the analysis software? Moreover, the fluo-
rescence-staining procedures must be robust and suitable for
automation; for example, they should require as few pipetting
steps as possible. Fluorescently labeled antibodies may be
preferable over primary and secondary antibody combinations.
Miniaturization and automation might also support combined
processing steps; for example, fixation and permeabilization
might be performed together, or all staining steps might be per-
formed in parallel.
Once a screening protocol is established, a pilot screen can be
performed on a smaller gene set to evaluate performance of the
assay protocol under high-throughput conditions. Miniaturiza-
tion and automation of experiments can reveal unexpected sour-
ces of problems that need to be solved before the full-scale
screen. A pilot screen also serves as a proof of concept, demon-
strating that the experimental design is suitable for screening at a
larger scale. Neumann et al. (2006) developed an automated
high-throughput approach for RNAi screening using time-lapse
imaging of a HeLa cell line stably expressing GFP-tagged
His2B (Neumann et al., 2006). In a pilot screen, they perturbed
49 genes by RNAi, demonstrating that the assay is suitable for
a genome-wide cell-cycle experiment (Neumann et al., 2010).Image Acquisition
Image acquisition is a crucial step for high-content screening
because the image quality determines the overall screen quality.
In this step, the image resolution and magnification must be
defined to capture the required details for the phenotype but
provide sufficient cell counts for robust statistics. When high
magnification is necessary, such as to analyze subcellular struc-
tures, several images per well may be required to capture a suf-
ficient number of cells. Exposure time is another critical factor
that must be adapted for each fluorescence channel. Most
automated microscopes have an autofocus option based either
on a hardware or software method. Exposure time and focus
are two variables that require multiple optimization iterations
and may require adaptation prior to imaging experiments.
Care must be taken to avoid imaging artifacts, such as uneven
illumination or a decaying light source during a high-content
screening experiment. Data handling and storage protocols
should also be established in parallel with assay development.
Large-scale imaging screens can easily produce several tera-
bytes in one experiment. A combinatorial RNAi screen per-
formed in our lab to measure genetic interactions produced
roughly 5.6 terabytes of imaging data from 160 384-well plates
(Laufer et al., 2013).
Image Analysis: From Images to Phenotypes
To deduce biological information from an image-based screen,
numeric measurements must be extracted and processed.
‘‘Computer vision’’ methodologies determine descriptors (fea-
tures) that summarize the information encoded by spatially
resolved pixel-intensity patterns (Danuser, 2011). The most suit-
able descriptors for implementing an analysis workflow depend
on the marker type used for imaging. Implementing image-anal-
ysis pipelines in parallel to optimizing the screening workflow is
preferred (Figure 3). In the following paragraphs, we review basic
analysis methods and describe how they can be applied for the
analysis of high-content screening data.
In high-content screening, phenotypes are defined as a com-
plex description of the cellular or organismal response toward an
experimental perturbation. In certain cases, phenotypes have
clear cell-biological correlates, such as large cells, mitotic cells,
and apoptotic bodies, but phenotypes can also be subtle
changes in the distribution of fluorescent markers. Computation-
ally, a phenotype is a vector of numeric features derived from the
analyzed image. These features are calculated for a region of in-
terest (ROI, e.g., individual cells or nuclei) or the entire image.
Identifying ROIs through computer-vision algorithms is referred
to as segmentation.
Image analysis can be roughly divided into two major analytic
steps. The first step includes image processing, object or ROI
identification, and feature extraction. This step is typically per-
formed with specialized image-analysis software such as Cell-
Profiler (Carpenter et al., 2006), EBImage (Pau et al., 2010), or
ImageJ/Fiji (Schindelin et al., 2012) (Table 1). These software
packages each have different advantages and disadvantages,
such as analysis speed or an intuitive user interface, but they
all perform most image-processing steps. The size of high-
throughput datasets can pose significant challenges for image
data processing; therefore, many image-analysis softwareCell 163, December 3, 2015 ª2015 Elsevier Inc. 1319
Table 1. Open-Source Image-Analysis Software
Name Type Website Reference Description
CellCognition time-lapse image analysis http://www.cellcognition.org/ (Held et al., 2010) CellCognition is a cross-platform
image-analysis software for the
analysis of time-lapse
experiments.
CellProfiler low- to high-throughput image
analysis
http://www.cellprofiler.org (Carpenter et al.,
2006)
Modular open-source software
with intuitive user interface.
CellProfiler
Analyst
machine-learning cell
classification
http://www.cellprofiler.org/ (Jones et al., 2008) CellProfiler Analyst is an open-
source software for exploring and
analyzing large, high-dimensional
image-derived data.
EBImage low- to high-throughput image
analysis, machine-learning cell
classification
http://www.bioconductor.org/
packages/release/bioc/html/
EBImage.html
(Pau et al., 2010) EBImage is an R package that
provides general purpose
functionality for the reading,
writing, processing, and analysis
of images.
Fiji/ImageJ general purpose image-analysis
software framework
http://fiji.sc/ (Schindelin et al.,
2012)
Fiji is a distribution of ImageJ for
the life sciences.packages facilitate distributed image processing on multi-CPU
clusters to decrease screening-experiment analysis times.
Image Data
The input data for computer-vision algorithms are images or
stacks of images, depending on the image-acquisition mode.
For high-content screens, the most commonly used approach
is multi-channel fluorescence microscopy. Depending on the
specimen size, these images can also resemble mosaics of
neighboring ROIs (e.g., tiles of a micro-well). Depending on the
microscopy camera detector, images feature different resolu-
tions (pixel dimensions) that currently range from 512 3 512 to
2,048 3 2,048 pixels with up to 65,536 different intensities.
Spatial or intensity binning can reduce image size; however,
this procedure results in loss/blurring, which might interfere
with image-analysis steps. A high-content experiment can yield
hundreds of thousands of images. For example, a screen
comprising 100 384-well plates imaged with three fluorescent
channels at four independent sites per well produces 460,800
images. As more dimensions are added to the experiment,
such as in time-lapse studies or for additional fluorescence
channels or confocal z stacks, storage capacity and computa-
tional infrastructure for data handling might become a limiting
factor.
Image Processing and Segmentation
First, images are imported, cropped to an equal size, registered,
and corrected for noise and illumination errors (Wang, 2007).
Noise can have different origins, such as random photon emis-
sion from the background (‘‘salt-and-pepper noise’’), staining ar-
tifacts, dirt speckles, or optic aberrations, such as laser beam
convolution. Often, noise can be corrected by applying different
types of filters, which all use kernel-based methods for image
smoothing (Wang, 2007). These filters can be linear, such as
mean, median, or Gaussian filters, or non-linear, such as the
Canny-edge filter (Rank and Unbehauen, 1992). After image
filtering, images with normalized and smoothened intensity his-
tograms can be passed to the next step of binarization. In this1320 Cell 163, December 3, 2015 ª2015 Elsevier Inc.step, each pixel is assigned to either the foreground or back-
ground. Binarization can be performed by applying either histo-
gram-based methods of dichotomization, such as Otsu’s
threshold, or local pixel neighborhood-dependent methods,
such as local adaptive threshold (Otsu, 1979). For cell segmen-
tation, the most commonly used method is to tag each region
of connected pixels in the binarized DNA channel as the nucleus.
Cell-body segmentation is often performed by Voronoi tessel-
lation-based methods, but also other methods, such as balloon-
growing algorithms (Benes and Zitova´, 2015), can be used.
Each ROI identified resembles one stained cell, and its outlines
can be used to control the segmentation process. For many
cases, this process is precise; however, several pitfalls must
be considered. Constructing a segmentation pipeline for one
particular image is often straightforward; however, the same
pipeline might over-segment or under-segment different images
in a large-scale dataset. Typically, in under-segmented images,
‘‘real’’ objects are not detected, but over-segmentation leads to
detection of background noise or other unrelated objects
(Thompson et al., 2014), and, thus, objects may be artificially
combined or split into several objects. Under screening condi-
tions, this is especially challenging because unexpected pheno-
types might not be captured by the test set used to optimize the
analysis. Thus, the pipelines should be optimized on a large and
diverse set of test images, such as those obtained through pilot
screening experiments. Ensuring sufficient quality of the seg-
mentation analysis is particularly important in large-scale
screens because segmentation quality is impossible to manually
control for hundreds of thousands of samples.
Extracting Numerical Features
Once objects are defined by the segmentation pipeline, numeric
features are extracted and quantitatively describe these re-
gions. Generic features, which can be extracted from objects
in fluorescence images, can be separated into four categories:
(1) marker-intensity features that describe the pixel-intensity
statistics of a certain channel inside the outline of the ROI; (2)
Figure 4. Image Analysis
Most image-processing pipelines follow the same
principal steps exemplified here.
(A) Images of Drosophila cells stained with fluo-
rescent markers for DNA, actin, and tubulin. First,
for object recognition, images need to be cor-
rected for stochastic and systematic errors, such
as salt-and-pepper noise, emission convolution, or
un-even specimen illumination patterns. Second,
all channels are binarized whereby each pixel
based on its properties or the properties of its
neighborhoods is assigned to either fore- or
background. After binarization, objects are defined
as connected areas of pixels. In case nuclei and
bodies should be segmented together, objects are
labeled in the DNA channel and expanded into the
binary body-objects mask by propagation of their
outlines.
(B) Image artifacts can hinder image analysis: ar-
tifacts can originate, e.g., from the image acquisi-
tion (illumination patterns, air bubbles, or dirt) or
sub-optimal image segmentation (such as under-
or over-segmentation).object-shape features that describe the geometric features of
each segmented object, such as its size or roundness; (3)
moment features that describe the spatial situation of objects
in the image, such as the direction of the major axis or center
of mass; and (4) texture features that describe the distribution
of pixel-intensity values throughout the ROI. Texture features
were first proposed by Haralick and Zernike and describe
how neighboring pixels inside an ROI interact, co-occur, or
distribute. In a recent study (Liberali et al., 2014), 200 features
from each single cell in high-content screens were extracted
and used to train a support vector machine based on super-
vised cell classification. Segmentation of 2 3 106 images was
based on DAPI and CellTrace staining and analyzed using Cell-
Profiler (Liberali et al., 2014).
Feature Reduction
Although several hundred features can be extracted from each
ROI, the features are often generic, and the connection to biolog-
ically interpretable phenotypes is unclear. As a next step,
different procedures can be used to reduce the number of fea-
tures, such as through selecting the features that provide non-Cell 163, Dredundant information using stepwise se-
lection algorithms (Fischer et al., 2015).
Alternatively, manual annotation or super-
vised or unsupervised machine learning
may be used to select informative fea-
tures (Held et al., 2010; Sommer and
Gerlich, 2013). These phenotypes often
reflect broader biological characteristics
and combine various generic features
(Fischer et al., 2015; Fuchs et al., 2010;
Neumann et al., 2010). Feature reduction
also aids in focusing on the most mean-
ingful features and removes unnecessary
data (Figures 5B and 5C). For example, in
many assays, the exact X-Y location of
each cell in the well is typically not linked
to a biological process triggered by aparticular perturbation and is discarded (Fischer et al., 2015;
Horn et al., 2011).
Image Analysis: How to Derive Biological Meaning
Phenotypic similarities can be used to cluster genes into func-
tionally related groups on the basis of the assumption that pertur-
bations triggering the same biological process will produce a
similar phenotype.Differentmethodscanbeused toclassify phe-
notypes: (1) Methods apply supervised clustering, whereby clas-
sifiers are trained on amanually curated dataset of ‘‘known’’ phe-
notypes. These classifiers are then applied to the full dataset to
categorize the perturbations. Such an analysis has been per-
formed, for example, in Fuchs et al. (2010) and Neumann et al.
(2010) for RNAi screens and in Loo et al. (2007) and Eggert
et al. (2004) for small-molecule screens (Eggert et al., 2004; Fuchs
et al., 2010; Loo et al., 2007; Neumann et al., 2010) (Figure 5D). (2)
Unsupervised methods, such as k-means or hierarchical clus-
tering, avoid restrictions imposed by the training dataset. These
methods are suitable for discovery of new unexpected pheno-
types in a dataset or when little is known about the datasetecember 3, 2015 ª2015 Elsevier Inc. 1321
Figure 5. Data Analysis
Data from image-based screens are analyzed by a
multi-step process.
(A) Quality-control plots to assess stability of as-
says. Positive and negative control distributions
should be well separated. Z’ factors are a measure
of assay performance as described in Zhang et al.
(1999). A Z’ factor > 0.5 indicates a very good
assay performance.
(B) Correlation of features between biological
replicates can be used to exclude features that are
not very reproducible.
(C) Correlation between features can reveal
redundant features. Clustering of features with
high correlations identify potentially redundant
features.
(D) Features can be summarized by supervised or
unsupervised classification into phenotypic clas-
ses. Shown are images of cells classified by a
supervised classification approach (Fuchs et al.,
2010).
(E) Genes or genetic interaction can be clustered
according to their feature vectors. A graph of genes
derived from a multi-parametric gene-gene inter-
action experiments is shown (Fischer et al., 2015).(Horn et al., 2011; Nir et al., 2010; Yin et al., 2013). Multi-variate
phenotype data can be visualized in many ways, such as clus-
tered network graphs, clustered heat maps, or phenotype repre-
sentations (Figure 5E). Specific graphical visualization methods
have been developed to display phenotypes and map features
onto abstract images of cells (Sailem et al., 2015), which is useful
for representing the biological meaning of features.
Quality control of image-analysis pipelines is performed on
multiple levels. The overall quality of images greatly impacts the
analysis results. Therefore, continuous efforts have to be under-
taken in screens to avoid or exclude artifacts. In large-scale
screens, quality of the images can be impacted by illumination
problems, dust, and other particles that need to be recognized
and excluded by the analysis workflow. Examples of problems
that occur in high-content screens are plentiful (examples are
shown in Figure 4B). After the analysis steps, the biological rele-
vance of the extracted data can be assessed on internal control
perturbations for which the cellular response is known. The per-
formance of control perturbations included in the screening
experiment also enables assessment of the quality of the exper-
imental and computational workflows (see also Figure 5A).Novel Assays and Screening Approaches
Currently, most high-content screens rely on antibody staining
for the proteins of interest or overexpression of fluorescently
tagged proteins or dyes. With new technologies to re-engineer
a cell’s genome, genetic modifications for new assays that
were previously feasible only in ESCs may soon be readily per-
formed in many cell types. In particular, it is now feasible in
almost all cell lines to create endogenously tagged fluorescent
proteins by homologous recombination using CRISPR/Cas9-
mediated genome engineering (Figure 6) (Kimura et al., 2015).
By identifying suitable short-guide (sg) RNA sites using different
available software tools (Heigwer et al., 2014; Montague et al.,1322 Cell 163, December 3, 2015 ª2015 Elsevier Inc.2014), donor templates can be used to recombine in-frame fluo-
rescent fusion proteins (Ran et al., 2013). This approach avoids
overexpressing tagged proteins or using BAC constructs and
might also facilitate use of multiple tagged proteins with different
fluorescent colors.
Instead of using artificial reporter constructs, CRISPR/Cas9-
mediated engineering will also facilitate generation of reporter
cell lines expressing fluorescent proteins that are controlled by
endogenous promotor and enhancer sequences. Such ap-
proaches have been broadly used in ESCs and in vivo and have
provided important insights into spatial and dynamic control of
cellular pathways (Lauschke et al., 2013); however, the ap-
proaches have been difficult to implement for screening assays
inmost commonlyusedcell lines.Theseapproachesarealso suit-
able for combining different colors, which should facilitate assays
that exceedcurrently availablemethodologies.Creatingmultiplex
assays will also become technically feasible. For example, multi-
ple components and transcriptional targets can be assessed in
parallel without further complex staining procedures that are
currently used in high-content screening (Figure 6C). Novel meth-
odologies that create sensitive, endogenous probes could further
enhance assay performance (Tanenbaum et al., 2014).
Another area of active development is improvement and
accessibility of image-analysis workflows to enhance multi-
parametric phenotype analyses. A recent survey has reported
that most published high-content screens are not multi-para-
metric and only partially make use of the richness of the image
data (Singh et al., 2014). Increasing information from image-
based screens by making software workflows more easily
accessible remains an important goal.Outlook and Concluding Remarks
During the past years, methods to automatically derive pheno-
types from image-based screens have matured and enabled
Figure 6. Novel Assays for High-Content
Screens
Schematic description on how to generate
endogenously tagged genes by CRISPR/Cas9-
mediated genome engineering.
(A) Endogenous reporter genes for image-based
screens can be generated by recombineering of
fluorescent proteins behind the start codon. A stop
cassette terminates the gene after the fluorescent
protein.
(B) Alternatively, proteins could be tagged to
monitor changes in localization or stability as in-
dicators for specific cellular processes.
(C) Genome engineering would also allow combi-
nation of multiple reporter/tagging approaches to
create multiplex assays that monitor signaling
pathway activity at multiple levels. HDR: homolo-
gous directed repair. RFP: red fluorescent protein.
CFP: cyan fluorescent protein.the application of high-content screening methods to many
biomedical questions. With the availability of additional pertur-
bation reagents and new developments in assay technologies,
it can be expected that visual, multi-parametric screening ap-
proaches will continue to advance the systematic understanding
of cellular processes. Nevertheless, there are a number of chal-
lenges on both the experimental as well as computational side
that will need further developments, including higher-resolution
microscopes and novel imaging modalities.
Currently, most screens have been performed on a limited
number of cell lines for which protocols for high-throughput
screening are readily available. For many biological assays the
question about the most relevant cell system remains often unre-
solved. In the future, isogenic cell-line models and induced
pluripotent cells (iPSCs) might enable the generation of more
specific cell models for basic as well as disease-relevant ques-
tions. Large collections of cell lines with defined genotypes
have previously been used to determine drug sensitivity using
cell growth and viability as a phenotypic read-out. Increasing
the complexity of the phenotypic read-out beyond lethality could
enable a deeper understanding of drug-gene relationships. In
addition, 3D cell models, such as organoids, might be adapted
for high-content screening experiments. Primary cell models
could also be used for phenotyping cells with complex genetic
backgrounds (Dermitzakis, 2012) and enable the use of image-
based phenotypes to dissect cellular correlates of complex traits.
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